Skip to main content
Equibles

Fi3 FINANCIAL ADVISORS, LLC

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1862427 INDIANAPOLIS, IN
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,890
-$123,828 QoQ
Shares Held
2,915
-90.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#138
of 162 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Fi3 FINANCIAL ADVISORS, LLC holds $696,693 across 4 Biotechnology names. LRMR ranks #4 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 2,651 $300,517
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,625 $280,521
3 MESO
Mesoblast Ltd
 7,891 $106,765
4 LRMR
Larimar Therapeutics, Inc.
This page 		2,915 $8,890

All Filings in LRMR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,890 2,915
2026-03-31 $132,718 29,493
2025-12-31 $111,716 29,322
2025-09-30 $94,445 29,240
2025-06-30 $69,857 24,172
2025-03-31 $51,535 23,970
2024-12-31 $92,098 23,798
2024-09-30 $133,534 20,387
2024-06-30 $147,805 20,387
2024-03-31 $193,150 25,448
2023-12-31 $115,788 25,448
2023-09-30 $101,005 25,571
2023-06-30 $79,965 25,548
2023-03-31 $115,732 25,548
2022-12-31 $105,513 25,548
2022-09-30 $318,624 99,570
2022-06-30 $238,763 121,818
2022-03-31 $493,362 121,818
2021-12-31 $1,314,416 121,818
2021-09-30 $1,404,561 121,818
2021-06-30 $1,196,252 121,818
2021-03-31 $310,433 21,248